论文部分内容阅读
目的总结接种无细胞百白破疫苗(DTaP)后出现血管性水肿不良反应1例的调查处置,为预防接种异常反应的处理提供借鉴。方法现场调查了解患儿既往过敏史、预防接种史及特殊病史;了解疫苗的来源、运输、贮存及使用等情况。结果根据患儿临床症状和体征,结合现场调查情况,县级预防接种异常反应专家诊断小组诊断为“血管性水肿”。患儿经抗过敏药物治疗后症状缓解并痊愈,未留后遗症。结论提高预防接种人员风险意识,做好接种前的详细询问,执行接种告知,可减少不良反应,避免纠纷。
Objective To summarize the investigation and treatment of one case of adverse reaction of angioedema after inoculation of cell-free diphtheria-pertussis vaccine (DTaP), and provide references for the prevention of abnormal response in vaccination. Methods Field investigation to understand the history of children with past allergies, vaccination history and special medical history; understand the source of the vaccine, transport, storage and use of such circumstances. Results According to the clinical symptoms and signs of the children, combined with the field investigation, the diagnosis team of expert on abnormal reaction of vaccination at county level was diagnosed as “angioedema”. Children with anti-allergic drug treatment and relief of symptoms and cure, leaving no sequelae. Conclusion To raise the risk awareness of vaccination personnel, make detailed inquiries before inoculation, and implement vaccination, reduce adverse reactions and avoid disputes.